Drug Profile
ACI 12589
Alternative Names: a-syn-PET tracer - AC Immune; ACI-12589Latest Information Update: 28 Mar 2024
Price :
$50
*
At a glance
- Originator AC Immune; Biogen
- Class Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Multiple system atrophy
- No development reported Parkinson's disease
Most Recent Events
- 28 Mar 2024 No recent reports of development identified for phase-I development in Parkinson's-disease(Diagnosis) in Switzerland
- 27 Oct 2023 Efficacy data from a clinical trial in Multiple system atrophy released by AC Immune
- 16 Mar 2022 Clinical trials in Multiple system atrophy (Diagnosis) in Sweden (unspecified route) before March 2022